MAPT and Alzheimer disease: Further investigation into the relationship between plasma NfL levels and Aβ/tau in advanced stages of AD, as well as the association between plasma NfL and typical AD‐related neuronal injury and cognitive phenotypes, may yield valuable insights into the role of plasma NfL in the context of AD.